Mytrus, Inc. is a clinical innovations technology and services company. The company offers Mytrus Enroll, an electronic informed consent and patient enrollment system for clinical trials that enables patients to learn the details of informed consent, as well as creates an environment for a focused and productive conversation with study staff. It provides solutions for pharmaceutical, biotech, and device makers. The company was founded in 2009 and is based in Davis, California.
105 East Street
Davis, CA 95616
Founded in 2009
Mytrus, Inc. Creates New Innovation Advisory Board
Mar 18 14
Mytrus, Inc. announced the creation of a new Innovation Advisory Board comprised of industry experts who will help shape the future of clinical products and services offered by the company. The six Innovation Advisory Board members include: Steven Cummings, MD is co-founder of Mytrus and an expert in the design and implementation of clinical research studies. Dr. Cummings, the Chief Scientific Officer at Mytrus, also serves as Director of the San Francisco Coordinating Center, Emeritus Professor of Medicine, Epidemiology and Biostatistics at UCSF and Senior Scientist at CPMC Research Institute and Innovator-in-Residence at Roche-Genentech. David G. Forster, JD, MA, CIP, Chief Compliance Officer, WIRB-Copernicus Group joined the Western Institutional Review Board in 1996 and currently serves as Chief Compliance Officer as well as a co-chair on a subcommittee of the Health and Human Services Secretary's Advisory Committee on Human Research Protections. Clay Johnston, MD, PhD is Dean of Medicine at the new University of Texas Dell Medical School in Austin. Dr. Johnston recently served as Director of the Clinical Translational Sciences Institute at the University of California, San Francisco, and an expert in clinical trial methods. Garry Neil, MD is Global Head of Research and Development at Medgenics and a leader in clinical trials innovation. At Johnson & Johnson, he served as Corporate Vice President of Science & Technology and Group President of Pharmaceutical Research and Development. Dr. Neil also is a Founder/Director and served as CEO of TransCelerate Biopharma Inc. Dr. John Orloff, MD is Global Head of Clinical Development at Merck Serono. Dr. Orloff recently served as Chief Medical Officer and Senior Vice President, Global Development for Novartis Pharma AG where he led the 'Trials of the Future' initiative to bring innovation to the drug development process. He also served as Head of U.S. Medical and Drug Regulatory Affairs for North America. Jane Perlmutter, PhD, MBA is a psychologist and leading patient advocate for clinical trial participants. Dr. Perlumutter also serves on the Clinical Trials Transformation Initiative on Informed Consent.